Home  »  Analyst Insights   »  AgeX Therapeutics Inc. (AGE) last month volatility...

AgeX Therapeutics Inc. (AGE) last month volatility was 15.82%: Don’t Ignore this Blaring Warning Signal

AgeX Therapeutics Inc. (AMEX: AGE) open the trading on January 03, 2022, with a bit cautious approach as it glided -12.84% to $0.95. During the day, the stock rose to $1.05 and sunk to $0.87 before settling in for the price of $1.09 at the close. Taking a more long-term approach, AGE posted a 52-week range of $0.52-$3.06.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free


>> 7 Top Picks for the Post-Pandemic Economy << 

Nevertheless, stock’s Earnings Per Share (EPS) this year is 11.60%. This publicly-traded company’s shares outstanding now amounts to $37.94 million, simultaneously with a float of $21.45 million. The organization now has a market capitalization sitting at $35.94 million. At the time of writing, stock’s 50-day Moving Average stood at $0.7274, while the 200-day Moving Average is $1.1495.

It is imperative to bring your focus towards the efficiency factor of the conglomerate that has a total of 6 employees. It has generated 169,818 per worker during the last fiscal year. Meanwhile, its income per employee was -987,727. The stock had 5.42 Receivables turnover and 0.33 Total Asset turnover. For the Profitability, stocks gross margin was +1.50, operating margin was -571.25 and Pretax Margin of -595.61.

AgeX Therapeutics Inc. (AGE) Ownership Facts and Figures

Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. AgeX Therapeutics Inc.’s current insider ownership accounts for 0.10%, in contrast to 17.70% institutional ownership.

AgeX Therapeutics Inc. (AGE) Earnings and Revenue Records

This company achieved a net margin of -581.64.

AgeX Therapeutics Inc.’s EPS increase for this current 12-month fiscal period is 11.60%.

AgeX Therapeutics Inc. (AMEX: AGE) Trading Performance Indicators

Let’s observe the current performance indicators for AgeX Therapeutics Inc. (AGE). It’s Quick Ratio in the last reported quarter now stands at 0.20. The Stock has managed to achieve an average true range (ATR) of 0.12. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 59.90.

In the same vein, AGE’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.23.

Technical Analysis of AgeX Therapeutics Inc. (AGE)

During the previous 9 days, stock’s Stochastic %D was recorded 56.70% While, its Average True Range was 0.1461.

>> 7 Top Picks for the Post-Pandemic Economy << 

Raw Stochastic average of AgeX Therapeutics Inc. (AGE) in the period of the previous 100 days is set at 49.65%, which indicates a major rise in contrast to 49.65% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 272.54% that was higher than 114.52% volatility it exhibited in the past 100-days period.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free



Download Free eBook For


100% free. stop anytime no spam

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

Sign up for Our Newsletter Now! Discover which stocks to trade!
100% Free. Stop Anytime. No Spam